Express

MEI Pharma Completes $100 Million Private Placement, to be Used for Litecoin Strategic Reserves

Summary: MEI Pharma announced the completion of a $100 million private placement, selling 29,239,767 shares of common stock or equivalent pre-funded warrants at a price of $3.42 per share, with the funds to be used for establishing Litecoin strategic reserves. The company also appointed Litecoin founder and lead investor in this private placement, Charlie Lee, to ...

MEI Pharma announced the completion of a $100 million private placement, selling 29,239,767 shares of common stock or equivalent pre-funded warrants at a price of $3.42 per share, with the funds to be used for establishing Litecoin strategic reserves. The company also appointed Litecoin founder and lead investor in this private placement, Charlie Lee, to join the board of directors, and designated GSR as its digital asset and fund management advisor to oversee the execution of the Litecoin reserve strategy. (businesswire)

Last Update:

Tags:
Link: MEI Pharma Completes $100 Million Private Placement, to be Used for Litecoin Strategic Reserves   [Copy]
  • Figma's IPO Triumph and Crypto Bet: How a Design Disruptor Stunned Wall Street After a ... 3 days ago
  • When Stablecoins Tear Down Banks’ Interest Margin Moats — A Third Look at the U.S. “Ge... 4 days ago
  • Twitter Space Highlight: Is Altcoin Season Coming? Unpacking BTC, Institutions & RWA 6 days ago
  • BTC Weekly: Momentum Top Divergence Signals Potential Shift Lower 6 days ago
  • The GENIUS Act & Stablecoin Regulation: BRG's Dominic Zagara on Crypto's Defining ... 9 days ago
  • You need to login to comment.